TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month August 14, 1992
